Quad Technologies Patents Novel T-Cell Activation Reagent for Car-T Cell Manufacturing – Business Wire (press release)
|
Quad Technologies Patents Novel T-Cell Activation Reagent for Car–T Cell Manufacturing
Business Wire (press release) WOBURN, Mass.–(BUSINESS WIRE)–Quad Technologies, a leader in cell and gene therapy bioprocessing reagents, announced today the U.S. Patent and Trademark Office has awarded the company a new U.S. Patent, No. 9,790,467, titled “Methods and … |
